FDA Approves Implantable Continuous Glucose Monitoring System

The first-ever implantable continuous glucose monitoring system has been approved by the U.S. Food and Drug Administration (FDA). The Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes will include a fully implantable sensor to detect glucose. It can be worn for up to 90 days.… Continue reading FDA Approves Implantable Continuous Glucose Monitoring System

Better Treatment for Hep C Patients

A new system can help identify which hepatitis C patients are most in need of new anti-viral drugs. An awareness campaign directed at baby boomers, born between 1946-1965, to be screened for hepatitis C , took off as effective treatments emerged to wipe out the liver-damaging virus. But high costs – up to more than… Continue reading Better Treatment for Hep C Patients